21三体综合征患儿先天性心脏病术后长期生存与死亡原因
该回顾性队列研究基于儿科心脏护理联盟数据,评估3376例21三体综合征(T21)患儿先天性心脏病(CHD)术后的无移植长期生存及死亡原因。30年生存率从室间隔缺损的92.1%到复杂共同房室通道的65.3%不等。匹配2185例T21与整倍体患儿后,中位随访22.86年,T21组死亡213例(9.7%)对比整倍体组123例(5.6%),校正后CHD相关死亡风险比为1.34(95%CI 0.92-1.97;
要点
- T21患儿CHD术后30年生存率因CHD类型差异大,室间隔缺损92.1%,复杂共同房室通道65.3%。
- T21患儿需终身监测其染色体异常相关的共病。
核心结论
- T21患儿心脏手术后的CHD相关死亡率与整倍体对照组相当。
- T21患儿需要终身监测与染色体异常相关的共病。
研究设计与样本
- 回顾性队列研究,数据来自儿科心脏护理联盟,并链接国家死亡指数和器官采购与移植网络的前瞻性数据。
- 纳入3376例符合标准的T21患者(75 155人年),其中2185例与整倍体CHD患者进行1:1匹配。
- 采用Kaplan-Meier法绘制生存曲线,多变量Cox比例风险模型分析死亡危险因素。
主要发现
- T21患者30年生存率范围从室间隔缺损的92.1%到复杂共同房室通道的65.3%。
- 匹配后中位随访22.86年(IQR 19.45-27.14年),T21组死亡213例(9.7%),整倍体组死亡123例(5.6%)。
临床怎么用
- T21患儿CHD术后长期生存与整倍体患儿相当,可据此进行预后咨询。
- 应重视T21患儿染色体异常相关共病的终身监测。
局限性
- 本研究为回顾性队列研究,可能存在选择偏倚和信息偏倚。
- 部分数据依赖直接标识符匹配,可能影响样本完整性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate long-term transplant-free survival and causes of death in the trisomy 21 (T21) population after surgery for congenital heart disease (CHD) in comparison with patients who are euploidic. STUDY DESIGN: This is a retrospective cohort study from the Pediatric Cardiac Care Consortium, enriched with prospectively collected data from the National Death Index and the Organ Procurement and Transplantation Network for patients with sufficient direct identifiers. Kaplan-Meier survival plots were generated and multivariable Cox proportional hazards models were used to examine risk factors for mortality between patients with T21 and 1:1 matched patients with comparable CHD who are euploidic. RESULTS: A long-term survival analysis was completed for 3376 patients with T21 (75 155 person-years) who met inclusion criteria. The 30-year survival rate for patients with T21 ranged from 92.1% for ventricular septal defect to 65.3% for complex common atrioventricular canal. Of these, 2185 patients with T21 were successfully matched with a patient who was euploidic. After a median follow-up of 22.86 years (IQR, 19.45-27.14 years), 213 deaths occurred in the T21 group (9.7%) compared with 123 (5.6%) in the euploidic comparators. After adjustment for age, sex, era, CHD complexity, and initial palliation, the hazard ratio of CHD-related mortality was 1.34 times higher in patients with T21 (95% CI, 0.92-1.97; P = .127). CONCLUSIONS: CHD-related mortality for patients with T21 after cardiac surgical intervention is comparable with euploidic comparators. Children with T21 require lifelong surveillance for co-occurring conditions associated with their chromosomal abnormality.
引用
- Peterson JK, Kochilas LK, Knight J, et al. Long-Term Survival and Causes of Death in Children with Trisomy 21 After Congenital Heart Surgery. J Pediatr. 2020. PMID: 33359302. doi:10.1016/j.jpeds.2020.12.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。